Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5 participants
INTERVENTIONAL
2022-04-05
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Benefits of Applying Neuroprosthesis to Improve Grasping and Reaching in Spinal Cord Injury Patients
NCT00221117
A User-friendly, Non-invasive Neuro-orthosis That Restores Volitionally Controlled Grasp Functions for SCI Survivors With Tetraplegia
NCT06087445
Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury
NCT02329652
Restoration of Hand Function in Cervical SCI
NCT06611748
Hand Function for Tetraplegia
NCT00890916
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In Aim 1, investigators will evaluate the ability of a non-invasive, user-controlled FES system to increase functional hand use in the homes of individuals with SCI. The research team will train participants to use the FES system for different functional hand movements and activities they identify as important to them, then measure FES system effectiveness using standardized assessments.
In Aim 2, investigators will assess the viability of using the sleeve technology to non-invasively record muscle activity as the participant attempts different functional movements.
In Aim 3, human-centric design methodology and contextual inquiry interviews will be employed to understand study participants' needs and preferences for a FES assistive device. This information will determine actions to improve usability and optimize the system for unsupervised home use.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-invasive FES
Wearable FES sleeve with non-invasive user controls
User-controlled FES system
Wearable FES sleeve with non-invasive user controls
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
User-controlled FES system
Wearable FES sleeve with non-invasive user controls
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥ 12 months post-SCI and medically/neurologically stable
* Cervical spinal cord injury (C1-C8); any etiology except neurodegenerative conditions
* Unable to grasp objects independently with both hands (tetraplegia)
* Manual muscle testing (MMT) scores ≥4/5 for elbow flexion and ≥2/5 for wrist extension
* Willing to participate in sessions at home or able to travel to alternate site for study sessions
Exclusion Criteria
* Poorly controlled autonomic dysreflexia (more than one episode in 3 months prior to enrollment)
* Moderate to severe spasticity (Modified Ashworth Scale (MAS) \>1+) in the hand, wrist, or forearm
* Received a localized injection (e.g. Botox) to hand, wrist, or forearm muscles within past 12 months
* Currently participating in physical rehabilitation for upper extremity impairments
* Individuals having or requiring any of the following: implanted pacemaker, life supporting/sustaining equipment, or critical non-removable implantable electronic devices such as an insulin pump or neurostimulator.
* Presence of any other clinically significant medical comorbidity and/or neurological condition for which participation in the study may pose a safety risk and/or influence results
* Presence of the following medical conditions: uncontrolled seizure disorder, active malignancy in the upper extremities, or open wounds/infections in the upper extremities
* Individuals whose forearm is determined to be too small or too large to fit the electrode sleeve being investigated
* Individuals who are pregnant or plan to get pregnant during the course of the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ohio State University
OTHER
Battelle Memorial Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David A Friedenberg, PhD
Role: PRINCIPAL_INVESTIGATOR
Battelle
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Battelle Memorial Institute
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
100144033
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.